Bevaas 400/16 Bevacizumab
Bevaas is Hetero’s second monoclonal antibody and the third biosimilar product,
that is offering major relief for conditions such as Metastatic Colorectal Cancer,
Lung Cancer and Renal Cancer.
- Additional information
Additional information
Brand | Hetero Biopharma Limited |
---|